Bipartisan Bill Seeks to Strengthen Oversight of Medicare Advantage
Lawmakers introduced the Medicare Advantage Improvement Act of 2026 to tighten prior authorization rules, boost transparency and curb practices that delay care.
Immunology-Focused Coultreon Adds $125M for Pills That Pack the Punch of Injectable Biologics
Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology target called SIK3. The Series A financing will support Phase 2 clinical trials in psoriasis and ulcerative colitis.
Executing Biologics Technology Transfer through Integrated Operating Models
As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion.
168历史查询®幸运168官方飞艇实时结果体彩网_飞行艇中国福彩查阅历史记录查询-Digitizing Medical Policy Alone Will Not Automate Prior Authorization at Scale
Many health plans are discovering that even after digitizing medical policies and implementing FHIR APIs, prior authorization turnaround times remain slow and provider frustration remains high. The reason is straightforward: digitization alone does not make medical‑necessity determinations executable by automated systems at scale.
As Health Costs Hit Record Highs, Brokers Face a Structural Test
This is forcing brokers to rethink how they serve clients and how their businesses continue to grow without sacrificing service.